Skip to content

News & Resources

Featured Stories

MilliporeSigma
MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant Read More
Posted on 5.8.24
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
Posted on 1.15.24
WhiteLab Genomics and Siren Biotechnology Announce Strategic Partnership to Accelerate AI-Powered Advancements in Gene Therapy
Posted on 11.1.23
Siren Biotechnology Awarded $4M in Grant Funding from the California Institute for Regenerative Medicine (CIRM)
Posted on 5.17.23
Siren Biotechnology Unveils Preclinical Data for Universal AAV Immuno-Gene Therapy for Cancer, a Novel Modality that Combines AAV Gene Therapy and Cytokine Immunotherapy
Posted on 5.17.23
Siren Biotechnology Launches to Pioneer Universal AAV Immuno-Gene Therapy for Cancer